Financing round-up: Optics11 Life, Cleara Biotech, Surge, Sanity Group, CimCure

The Netherlands: CimCure, a Dutch biotech company focusing on the development of vaccine-based immunotherapy, Covalab, a France-based biotechnology company specializing in the development and production of recombinant proteins and antibodies for diagnostics and therapeutics, Amsterdam UMC and the University of Zurich, have received a €1.06m (US$1.06m) grant from EUREKA Eurostars. With a total budget of…

You must be a HMI Subscriber to view this content.

Subscribe Now »